NMN vs NR
Two supplements that both raise NAD+ — but they're not identical. Here's a straightforward comparison to help you choose.
NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are both NAD+ precursors. They converge on the same pathway — both ultimately become NAD+ inside your cells. The practical differences come down to absorption, cost, and availability.
This guide is for you if: You want to raise your NAD+ levels and aren't sure whether to choose NMN or NR, want to compare the evidence for each, or want the best option for your budget in India.
See the evidenceQuick verdict
Both work. NMN is the better choice for most Indians — it's significantly cheaper from domestic brands, widely available, and the evidence gap is closing rapidly. NR (as Tru Niagen) has more published long-term safety data but costs 2–3x more since it's mostly imported.
Head-to-head comparison
| NMN | NR (Niagen) | |
|---|---|---|
| Chemical pathway | NMN → NAD+ (one step) | NR → NMN → NAD+ (two steps) |
| Cell entry | Slc12a8 transporter (direct) + conversion to NR | ENT transporters + NRK1/2 conversion |
| Typical dose | 250–500 mg/day | 300–500 mg/day |
| Human RCTs | Growing (10+ published) | More extensive (15+ published) |
| Safety data | Good (up to 1,250 mg/day studied) | Excellent (up to 2,000 mg/day, longer follow-up) |
| Cost (India) | ₹1,500–3,000/month | ₹3,500–5,500/month |
| Availability | Domestic brands (Decode Age, Sharrets) | Mostly imported (Tru Niagen via iHerb) |
| FDA status (US) | Removed from supplement status (2022) | Grandfathered as dietary supplement |
Which should you pick?
- Choose NMN if: You're in India and want the best value, prefer domestic brands, want the "one step closer to NAD+" argument, or are taking 250–500 mg/day
- Choose NR if: You prioritise long-term safety data, want the most-studied option, don't mind the higher cost, or prefer a patented/standardised ingredient (Niagen)
- Either way: Pair with TMG (500 mg/day) for methylation support. Take in the morning on an empty stomach. Don't take both — they converge on the same pathway.
For most Indians, NMN 250–500 mg/day from a reputable domestic brand + TMG 500 mg/day is the best balance of cost, convenience, and evidence. Take both in the morning.
Track whether your NAD+ strategy is working
eterni connects your supplement stack to your biomarkers — see the trajectory, not just a snapshot.
Get early accessFrequently Asked Questions
Is NMN or NR better for raising NAD+ levels?
Both raise NAD+ effectively in human trials. NMN may have a slight edge due to the Slc12a8 transporter allowing direct cellular uptake, but NR has more published long-term safety data. Practical differences in NAD+ elevation are modest at equivalent doses.
Why was NMN removed from supplement status in the US?
In late 2022, the FDA ruled NMN could not be sold as a dietary supplement in the US because Metro International Biotech had filed it as an investigational new drug. NR (as Niagen) was already established as a supplement before any drug investigations began, so it was not affected. This ruling does not apply in India.
Can I take NMN and NR together?
There is no strong rationale for combining both since they converge on the same NAD+ synthesis pathway. Most longevity practitioners recommend choosing one precursor and pairing it with TMG to support methylation rather than doubling up on precursors.
Which NAD+ precursor is more affordable in India?
NMN is significantly cheaper in India, ranging from ₹1,500–3,000/month for 250–500 mg/day from domestic brands like Decode Age or Sharrets. NR (Tru Niagen) is typically imported and costs ₹3,500–5,500/month, making NMN the better value option for most Indian consumers.
The biochemistry of NMN vs NR
Both NMN and NR are precursors in the NAD+ salvage pathway — the dominant route for NAD+ synthesis in most tissues. The pathway: Nicotinamide → NMN (via NAMPT) → NAD+ (via NMNAT). NR enters this pathway by being converted to NMN via NRK1/NRK2 kinases.
The NMN transport question: For years, it was assumed NMN was too large to cross cell membranes directly and must be converted to NR first (via CD73). The 2019 discovery of the Slc12a8 transporter in the small intestine changed this — NMN can enter enterocytes directly. However, the relative contribution of direct transport vs NR conversion in humans remains debated.
Human trial data: NR has more published human trials — the NICE-AGE study, NRPT studies, and multiple ChromaDex-funded trials show consistent NAD+ elevation (40–90% at 300–1,000 mg/day). NMN human data has grown rapidly since 2021, with studies from Japan, China, and the US showing similar NAD+ increases at 250–600 mg/day. Neither has shown serious adverse effects in any published trial.
Know what's working. Know what's not.
eterni connects your lab results, supplements, and retests — so you can see the trajectory, not just a snapshot.
Join the waitlist